Doxazosin Mesylate
Brand name: Doxazosin Mesylate
Rank #467 of 500 drugs by total cost
$15.7M
Total Cost
729,878
Total Claims
$15.7M
Total Cost
24,364
Prescribers
$22
Cost per Claim
96,089
Beneficiaries
1,630,316
30-Day Fills
$645
Avg Cost/Provider
30
Avg Claims/Provider
About Doxazosin Mesylate
Doxazosin Mesylate (sold as Doxazosin Mesylate) was prescribed 729,878 times by 24,364 Medicare Part D providers in 2023, costing the program $15.7M. At $22 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 464 | Hydrocortisone (Hydrocortisone) | $15.9M | 762,398 |
| 465 | Digoxin (Digoxin) | $15.9M | 548,410 |
| 466 | Alpelisib (Piqray) | $15.7M | 747 |
| 467 | Doxazosin Mesylate (Doxazosin Mesylate) | $15.7M | 729,878 |
| 468 | Prucalopride Succinate (Motegrity) | $15.7M | 22,068 |
| 469 | Ketorolac Tromethamine (Ketorolac Tromethamine) | $15.6M | 582,750 |
| 470 | Tetrabenazine (Tetrabenazine) | $15.6M | 6,326 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology